VePesid-Ifosfamide-Platinol Regimen

BACKGROUND To compare the efficacy of one cycle of standard dose cisplatin, etoposide, and ifosfamide (VIP) plus three cycles of… Expand

Peripheral T-Cell lymphomas (PTCL) are relatively rare diseases but appear to be highly aggressive and display worse remission… Expand

OBJECTIVE This prospective randomized trial compared the Angio-Seal VIP with Perclose Proglide and to manual compression with… Expand

BACKGROUND Various staging systems have been proposed for disseminated germ cell neoplasms. The Indiana University staging system… Expand

PURPOSE Patients with disseminated germ cell cancer and poor prognosis (International Germ Cell Cancer Collaborative Group… Expand

Targeted delivery of radionuclides and therapeutic agents to specific biomarkers of breast cancer has important implications for… Expand

PURPOSE To compare first-line high-dose chemotherapy (HD-CT) with autologous blood stem-cell transplantation to standard-dose… Expand

PURPOSE To compare standard therapy with bleomycin, etoposide, and cisplatin (BEP) to experimental therapy with etoposide… Expand

PURPOSE A treatment program that included high-dose carboplatin, etoposide, and cyclophosphamide (CEC) followed by autologous… Expand

STUDY OBJECTIVE To determine the efficacy of the addition of ifosfamide to cisplatin plus etoposide (VIP), or vinblastine (VeIP… Expand